Drägerwerk KGaA (XTRA:DRW3) just posted third quarter and nine month results that showed slightly softer quarterly profit alongside higher sales, while the longer period featured stronger earnings and a wider gap to last year.
The latest results land after a choppy few months for Drägerwerk KGaA, with the share price down 12.02% over the past 30 days but still showing a strong 54.09% share price return year to date and a 45.54% total shareholder return over one year. This points to momentum that has cooled recently rather than fully reversing.
Capitalize on Drägerwerk KGaA’s earnings momentum and benchmark it against hand picked peers by scanning our 200 high quality undervalued stocks with resilient balance sheets and solid cash generation.Bulls point to stronger nine month earnings and a long track record in critical care equipment. Bears see the recent share price slip as a warning. Which side does Drägerwerk KGaA’s current valuation support?
Most Popular Narrative: 4% Undervalued
On the most followed view of Drägerwerk KGaA, the market price of €105.40 sits modestly below a fair value estimate of €110.25, with analysts tying that gap to earnings quality and recurring services rather than headline sales growth.
The expanding base of connected systems and services, with service revenue above €1b in 2025 and services already exceeding device sales in several European markets including Germany, sets up further growth in recurring revenue that can smooth cash flows and support more resilient margins.
See why 5 investors see Drägerwerk KGaA as 4% undervalued.
Result: Fair Value of €110.25 (UNDERVALUED)
Still, the thesis can unravel if tariff costs stay elevated or if the Medical division fails to move from current losses to consistent profit.
Find out about the key risks to this Drägerwerk KGaA narrative.
Next Steps
Mixed signals on Drägerwerk KGaA so far. If you want to move fast and decide for yourself, start by weighing the 4 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Drägerwerk KGaA?
If you want to keep your edge and avoid leaving potential opportunities on the table, use the Simply Wall Street Screener to surface fresh, data driven ideas fast.
- Target undervalued quality by scanning companies with solid fundamentals using the 200 high quality undervalued stocks.
- Prioritise resilience and sleep easier by focusing on businesses with strong finances through the list of solid balance sheet and fundamentals (203 results).
- Spot potential future winners early by running a focused search across 605 high quality undiscovered gems.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com